Combination therapy achieves high rates of response for patients with ALL
A combination of ponatinib and blinatumomab was found to be safe and highly effective in patients with newly diagnosed or relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), according ...
May 20, 2021
0
19